Annovis Uses AI Platform to Accelerate Buntanetap FDA Filing
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) is integrating Weave Bio’s artificial intelligence platform into preparations for a planned buntanetap New Drug Application, aiming to shorten the time between …
Annovis Uses AI Platform to Accelerate Buntanetap FDA Filing Read More